U.S. Biotech Stock News

Earlier this week, Hims & Hers Health said clinicians on its platform can now prescribe Eli Lilly GLP-1 weight loss drugs, which will be filled through LillyDirect, adding to existing access to Novo Nordisk’s Wegovy and other branded treatments. This move strengthens Hims & Hers’ role as a prescribing hub in the fast-growing GLP-1 care ecosystem by plugging directly into major drugmakers’ distribution channels. Next, we’ll examine how integrating Eli Lilly’s GLP-1 treatments through...

If you are wondering whether Lam Research shares still offer value after a strong run, or if you are turning up late to the party, this breakdown can help you frame the risk and reward trade off more clearly. The stock closed at US$265.55 and has posted returns of 0.1% over 7 days, 13.8% over 30 days, 43.5% year to date, 300.9% over 1 year, 449.5% over 3 years and 339.0% over 5 years. Recent headlines around Lam Research have focused on its role in semiconductor equipment, its exposure to...

Wondering whether Valley National Bancorp at around US$13.25 is offering fair value or an appealing entry point? This article walks through what the current price could imply for you as a shareholder. The stock has moved 0.8% over the last 7 days, 10.4% over the past month, 13.3% year to date, 60.0% over 1 year and 78.5% over 3 years, compared with a 17.8% return over 5 years. Recent coverage has focused on how regional banks are being reassessed by investors, and how balance sheet strength,...

Medline stock snapshot after recent moves Medline (MDLN) has attracted fresh attention after recent trading, with the share price at $47.16 and single-day, week, and month returns of around 1%, 2%, and 11% respectively. See our latest analysis for Medline. Over the past month Medline has logged an 11.0% share price return and a 16.1% year to date share price return, suggesting near term momentum is firming even though very short term moves have been softer. If you are comparing Medline with...

Moody's (MCO) opened 2026 with Q1 revenue of US$2.1b and basic EPS of US$3.74, setting the tone for how its profitability story is developing against a US$466.72 share price. Over recent quarters, revenue has moved from US$1.67b in Q4 2024 to between US$1.89b and US$2.08b across the last five reported periods, while quarterly basic EPS ranged from US$2.18 to US$3.74, underscoring how earnings power has tracked alongside higher net income figures. With a trailing net margin cited at 31.7%, the...

If you are wondering whether FactSet Research Systems at around US$242.72 is starting to look interesting, the valuation picture is where the answers begin. The share price has moved 5.2% over the last 7 days and 16.4% over the last 30 days, even though the year to date return is a 14.8% decline and the 1 year return is a 42.1% decline, with 3 year and 5 year returns of 37.5% and 24.2% declines respectively. These moves come against a backdrop where investors are reassessing expectations for...

Wondering if Public Storage at around US$304.81 is a fair deal or a premium price tag? This breakdown is designed to help you weigh what you are really getting for each dollar invested. The stock has recently posted returns of 1.7% over 7 days, 12.3% over 30 days, 17.9% year to date, 7.6% over 1 year, 19.4% over 3 years and 38.5% over 5 years. This puts recent price action front and center for anyone thinking about value. Recent news flow around Public Storage has focused on its position as...

Investors may be wondering if Royal Caribbean Cruises at around US$265 per share still offers value after its long run, or if most of the upside has already been priced in. The stock is down 5.9% over the last week and 4.8% over the last month, yet it still shows a 29.9% return over 1 year and a very large gain over 3 years. Recent headlines have focused on the cruise sector’s recovery, capacity ramp ups, and demand trends for leisure travel. This helps frame why investors have been willing...

Why Mobileye’s latest earnings matter for investors Mobileye Global (MBLY) reported first quarter results that paired higher sales with a sizeable goodwill impairment and net loss, followed by an increase in its 2026 revenue outlook and the announcement of a US$250 million share repurchase program. See our latest analysis for Mobileye Global. At a share price of US$7.90, Mobileye’s recent 7 day share price return of 2.33% follows a much weaker run, with a 90 day share price return of 24.83%...

Highwoods Properties (NYSE:HIW) has authorized a $250 million share repurchase program. The company plans to fund the buybacks through sales of non core assets in its portfolio. The move reflects a shift in how Highwoods is choosing to allocate capital between assets and its own shares. Highwoods Properties enters this announcement with its shares recently closing at $23.74. The stock is up 2.4% over the past week and 11.7% over the past month, while the year to date return stands at a...

If you are wondering whether Public Service Enterprise Group at around US$78.51 is offering fair value or a margin of safety right now, this article breaks down what the current price might be indicating. The stock is currently around US$78.51, with returns of a 3% decline over the past week, a 1.6% decline over the past month, a 3.1% decline year to date, and a 1% decline over 1 year, but gains of 38.8% over 3 years and 48.6% over 5 years that some investors may see as relevant context when...

In April 2026, Andretti Performance announced a partnership making Velo3D the official sponsor and additive manufacturing technology provider for two 2026 IMSA Michelin Pilot Challenge events, featuring Velo3D branding on the No. 43 Porsche at Laguna Seca and Indianapolis and race-ready components produced with its metal 3D printing systems. A custom aluminum CP1 radio controls mounting bracket, produced using Constellium’s Aheadd CP1 alloy and generative design tools, puts Velo3D’s...

Why FormFactor’s latest industry appearance matters for shareholders FormFactor (FORM) is drawing fresh attention after President and CEO Mike Slessor presented at the International Semiconductor Industry Group Symposium in Sunnyvale, an event closely watched by investors focused on artificial intelligence hardware. See our latest analysis for FormFactor. That symposium appearance comes after a period of powerful momentum, with a 30 day share price return of 50.39% and year to date share...

If you are wondering whether Archer-Daniels-Midland is still reasonably priced after its recent run, or if you are arriving late to the story, this article focuses squarely on what you are getting for the current share price. With the stock at US$69.43, recent returns stand at 3.7% over 7 days, 2.1% over 30 days, 17.6% year to date and 49.4% over 1 year. This naturally prompts questions about how the current price stacks up against underlying value and risk. Recent coverage has centered on...

Recent share performance and business overview Dream Finders Homes (DFH) has drawn attention after recent share price moves, with a return of about 10% over the past month and a decline of roughly 19% over the past 3 months. The US homebuilder, headquartered in Jacksonville, Florida, reports revenue of about US$4.3b and net income of roughly US$203.7m. This reflects its mix of single family homebuilding and related financial services across several regional segments. See our latest analysis...

EQT (EQT) kicked off Q1 2026 with revenue of US$3.6 billion and basic EPS of US$2.38, alongside trailing twelve month revenue of US$9.4 billion and EPS of US$5.31. This sets a clear earnings bar for investors tracking the story. Over recent quarters the company has seen revenue move from US$2.4 billion in Q1 2025 and US$1.8 billion in Q4 2024 to US$3.6 billion in the latest quarter. Basic EPS has increased from US$0.40 and US$0.70 in those same periods to US$2.38, putting the focus firmly on...

If you are wondering whether California Resources at around US$64.65 is still offering value or starting to look fully priced, this breakdown will help you make sense of what the current market price might be implying. The stock has been relatively flat over the last 7 days with a 0.4% decline, but over longer periods it has delivered returns of 1.3% over 30 days, 39.4% year to date, 91.4% over 1 year, 81.2% over 3 years and 207.3% over 5 years. Recent coverage of California Resources has...

Metropolitan Bank Holding Corp. recently reported first-quarter 2026 results, with net interest income rising to US$85.91 million and net income to US$31.43 million, while also increasing its quarterly dividend to US$0.25 per share. The combination of stronger earnings per share from continuing operations and a higher dividend suggests management’s confidence in the bank’s current profitability and capital position. We’ll now examine how this earnings strength and dividend increase may...

Why Star Bulk Carriers Is On Investors’ Radar Star Bulk Carriers (NasdaqGS:SBLK) has drawn attention after a strong year of share-price and total-return performance, putting its dry bulk shipping business, financial profile, and valuation in sharper focus for income and value oriented investors. See our latest analysis for Star Bulk Carriers. Momentum has been building, with a 1 month share price return of 8.81% and a 90 day share price return of 15.76%. The 1 year total shareholder return of...

What recent performance reveals about Stock Yards Bancorp Stock Yards Bancorp (SYBT) has attracted attention after a one-month return of about 9.8%, alongside a gain of nearly 3.9% over the past three months, contrasting with a 6.4% decline over the past year. See our latest analysis for Stock Yards Bancorp. The recent 9.8% 1 month share price return, alongside an 8.1% year to date share price return and a 6.5% decline in 1 year total shareholder return, suggests improving short term momentum...

Ardelyx (NasdaqGM:ARDX) appointed Felecia W. Ettenberg as Chief Legal Officer, succeeding Elizabeth Grammer. The transition follows Grammer’s 16 year tenure in the role. Ettenberg brings extensive legal and regulatory experience from a leading pharmaceutical company. Ardelyx focuses on therapies in the biopharmaceutical space, where regulatory scrutiny, patent protection, and compliance requirements shape how companies operate. A new Chief Legal Officer sits at the center of these issues,...

Veeco Instruments stock in focus Veeco Instruments (VECO) is back on many investors’ screens after recent share price moves, with the stock closing at $50.37 and posting double digit returns over the past month and past 3 months. See our latest analysis for Veeco Instruments. The recent 7 day share price return of 18.1% and 30 day share price return of 59.4% sit alongside a 1 year total shareholder return of 176.8%. This points to strong momentum that has been building over time. If you are...

Navitas Semiconductor (NVTS) is back in focus after investors responded to its board shake up, its upcoming earnings release on May 5, 2026, and its ongoing shift toward AI focused power chips. See our latest analysis for Navitas Semiconductor. The share price has surged in recent weeks, with a 30 day share price return of 101.2% and a 1 year total shareholder return that is very large, as investors weigh the AI focused pivot, new board appointment, and the upcoming earnings release...

If you are wondering whether Synchrony Financial at around US$78.69 is still offering value or has already priced in the story, this breakdown will help frame what the current share price might be implying. The stock shows a mixed recent picture, with a 3.6% move over the last 7 days, 18.2% over 30 days, a year to date return of a 7.0% decline, and 60.5% over the past year, alongside a very large 3 year outcome and 104.6% over 5 years. Recent coverage has focused on Synchrony Financial's...